Notice of Intent To Grant a Partially Exclusive Patent License; Intellikine, Inc., 6399 [E9-2614]

Download as PDF Federal Register / Vol. 74, No. 25 / Monday, February 9, 2009 / Notices all applicable product safety rules as defined in the CPSA or similar rules, bans, standards, or regulations under any other Act enforced by the Commission will remain prohibited in accordance with section 19 of the CPSA as amended by CPSIA. sroberts on PROD1PC70 with NOTICES II. The Stay The United States Consumer Product Safety Commission hereby stays applicability to manufacturers, including importers, of the requirements for testing and certification 8 of products set forth in paragraphs 14(a)(1), (2) and (3) of the CPSA, as amended by subsection 102(a) of CPSIA, with the exception of: (1) The requirements of any CPSC regulation, or of subsection 14(a) of the CPSA as it existed prior to amendment by the CPSIA, for product testing and certification, including existing requirements for certification of automatic residential garage door openers, bike helmets, candles with metal core wicks, lawnmowers, lighters, mattresses, and swimming pool slides; 9 and (2) The certifications required due to certain requirements of the Virginia Graeme Baker Pool & Spa Safety Act being defined as consumer product safety ‘‘rules;’’ and (3) The certifications of compliance required for ATVs in section 42(a)(2) of the CPSA which were added by CPSIA; and (4) Any voluntary guarantees provided for in the Flammable Fabrics Act (‘‘FFA’’) or otherwise (to the extent a guarantor wishes to issue one); and (5) The requirements on manufacturers, including importers, of children’s products to use third party laboratories to test and to certify, on the basis of that testing, compliance of children’s products with: • Requirements on the lead content of paint and other surface coatings effective for products manufactured after December 21, 2008; including a rule declaring a consumer product to be a banned hazardous product or substance.’’ CPSA at § 14(f)(1), as amended by CPSIA § 102(b). 8 By immediate final rule published November 18, 2008 (73 FR 68,328–32), the Commission limited the testing and certification requirement to importers and U.S. domestic manufacturers. 9 Prior to amendment by the CPSIA, § 14(a) of the CPSA required testing and issuance of a certification for each product subject to a CPSA consumer product safety standard, namely a product subject any requirement of 16 CFR parts 1201 through 1213, e.g., part 1205 for walk-behind power mowers or part 1211 for automatic residential garage door operators. Certain CPSC regulations themselves require certification of compliance or a statement of conformity. See, e.g. 16 CFR part 1633 for flammability (open flame) of mattresses or 16 CFR 1500.17(a)(13(i)(B) for candles made with metal-cored wicks. VerDate Nov<24>2008 16:35 Feb 06, 2009 Jkt 217001 6399 • Requirements applicable to full-size and non-full-size cribs and pacifiers effective for products manufactured after January 20, 2009; • Requirements concerning small parts effective for products manufactured after February 15, 2009; and • Requirements on the lead content of metal components of children’s metal jewelry effective for products manufactured after March 23, 2009. This action by the Commission does not stay the requirement that products meet all applicable product safety rules as defined in the CPSA or similar rules, bans, standards, or regulations under any other Act enforced by the Commission. Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500. FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500, telephone: 301–319–7428. Dated: February 2, 2009. Todd A. Stevenson, Secretary, Consumer Product Safety Commission. [FR Doc. E9–2590 Filed 2–6–09; 8:45 am] Notice of Proposed Information Collection Requests BILLING CODE 6355–01–P DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent To Grant a Partially Exclusive Patent License; Intellikine, Inc. Department of the Navy, DoD. Notice. AGENCY: ACTION: SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to Intellikine, Inc., a revocable, nonassignable, partially exclusive license to practice worldwide the Government owned inventions described in U.S. Patent 6,632,789 entitled ‘‘Methods for Modulating T Cell Responses by Manipulating Intracellular Signal Transduction’’ issued 14 October 2003 and related foreign filings in the fields of diagnosis, prevention and/or treatment of disease in humans and/or animals utilizing methods for modulating T cell responses by manipulating intracellular signals associated with T cell costimulation. DATE: Anyone wishing to object to the grant of this license has fifteen (15) days from the date of this notice to file written objections along with supporting evidence, if any. Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910–7500, telephone: 301–319–7428. ADDRESSES: Written objections are to be filed with the Office of Technology Transfer, Naval Medical Research PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Dated: February 3, 2009. A.M. Vallandingham, Lieutenant Commander, Judge Advocate General’s Corps, U.S. Navy, Federal Register Liaison Officer. [FR Doc. E9–2614 Filed 2–6–09; 8:45 am] BILLING CODE 3810–FF–P DEPARTMENT OF EDUCATION Department of Education. The Director, Information Collection Clearance Division, Regulatory Information Management Services, Office of Management, invites comments on the proposed information collection requests as required by the Paperwork Reduction Act of 1995. DATES: Interested persons are invited to submit comments on or before April 10, 2009. SUPPLEMENTARY INFORMATION: Section 3506 of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35) requires that the Office of Management and Budget (OMB) provide interested Federal agencies and the public an early opportunity to comment on information collection requests. OMB may amend or waive the requirement for public consultation to the extent that public participation in the approval process would defeat the purpose of the information collection, violate State or Federal law, or substantially interfere with any agency’s ability to perform its statutory obligations. The Director, Regulatory Information Management Services, Office of Management, publishes that notice containing proposed information collection requests prior to submission of these requests to OMB. Each proposed information collection, grouped by office, contains the following: (1) Type of review requested, e.g., new, revision, extension, existing or reinstatement; (2) Title; (3) Summary of the collection; (4) Description of the need for, and proposed use of, the information; (5) Respondents and frequency of collection; and (6) Reporting and/or Recordkeeping burden. OMB invites public comment. The Department of Education is especially interested in public comment AGENCY: SUMMARY: E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 74, Number 25 (Monday, February 9, 2009)]
[Notices]
[Page 6399]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2614]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant a Partially Exclusive Patent License; 
Intellikine, Inc.

AGENCY: Department of the Navy, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Intellikine, Inc., a revocable, nonassignable, partially 
exclusive license to practice worldwide the Government owned inventions 
described in U.S. Patent 6,632,789 entitled ``Methods for Modulating T 
Cell Responses by Manipulating Intracellular Signal Transduction'' 
issued 14 October 2003 and related foreign filings in the fields of 
diagnosis, prevention and/or treatment of disease in humans and/or 
animals utilizing methods for modulating T cell responses by 
manipulating intracellular signals associated with T cell 
costimulation.

DATE: Anyone wishing to object to the grant of this license has fifteen 
(15) days from the date of this notice to file written objections along 
with supporting evidence, if any. Written objections are to be filed 
with the Office of Technology Transfer, Naval Medical Research Center, 
503 Robert Grant Ave., Silver Spring, MD 20910-7500, telephone: 301-
319-7428.

ADDRESSES: Written objections are to be filed with the Office of 
Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500, telephone: 301-319-7428.

    Dated: February 3, 2009.
A.M. Vallandingham,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
[FR Doc. E9-2614 Filed 2-6-09; 8:45 am]
BILLING CODE 3810-FF-P